A newly allowed US patent covers the lipid delivery system behind Daewoong’s experimental mRNA platform for reprogramming aged cells.
Link as first comment.

A newly allowed US patent covers the lipid delivery system behind Daewoong’s experimental mRNA platform for reprogramming aged cells.
Link as first comment.